Home › Calculator › PMCB Dividend Calculator 2026
PMCB Dividend Calculator 2026
No dividendHealthcarePharmaCyte Biotech, Inc. · NASDAQ
Price: $0.35 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
PMCB is not a dividend-focused stock
PMCB pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
PMCB Dividend Yield
PharmaCyte Biotech, Inc. (PMCB) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When PMCB pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About PharmaCyte Biotech, Inc. (PMCB) — Dividend Analysis 2026
PharmaCyte Biotech, Inc. is a biotechnology firm dedicated to the development and commercialization of advanced cellular therapies within the United States. Their primary therapeutic areas include various forms of cancer, diabetes, and malignant ascites. Central to their efforts is Cell-in-a-Box, their proprietary encapsulation technology which utilizes cellulose to enclose live cells. This innovative platform serves as the foundation for treatments aimed at diverse cancers, such as advanced and inoperable pancreatic cancer, as well as diabetes. The company's pipeline includes therapies for pancreatic and other solid cancerous tumors; a treatment for Type 1 and insulin-dependent Type 2 diabetes involving encapsulated, genetically modified insulin-producing cells; and cancer treatments derived from cannabis plant compounds. To further its research, PharmaCyte maintains collaborative agreements: one with the University of Technology, Sydney, for the creation of melligen cells to combat diabetes, and another with the University of Northern Colorado, focusing on methods for identifying, separating, and quantifying cannabis constituents. Originally established in 1996, the company operated under the name Nuvilex, Inc. before rebranding as PharmaCyte Biotech, Inc. in January 2015. Its corporate headquarters are located in Las Vegas, Nevada.
PMCB Dividend & DRIP — Frequently Asked Questions
Does PMCB pay a dividend?
No. PharmaCyte Biotech, Inc. (PMCB) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of PMCB?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does PMCB have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. PMCB has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to PMCB
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full PMCB DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open PMCB position with:
🌍 PMCB Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold PMCB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 PMCB Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 PMCB Dividend Payment Schedule
PMCB pays quarterly — 4 times per year. Ex-div: —.
📊 PMCB vs Healthcare Benchmarks
How PMCB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PMCB sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ PMCB Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-03-31 | 119,170 | $0.67 | $79.8K | ||
| A-Award | 2026-03-31 | 119,170 | $0.67 | $79.8K | ||
| A-Award | 2026-03-31 | 119,170 | $0.67 | $79.8K | ||
| A-Award | 2026-03-31 | 119,170 | $0.67 | $79.8K | ||
| Buy | 2026-01-07 | 40,000 | $0.83 | $33.3K | ||
| Buy | 2026-01-06 | 30,000 | $0.79 | $23.7K | ||
| Buy | 2026-01-05 | 30,000 | $0.78 | $23.5K | ||
| Buy | 2026-01-07 | 20,000 | $0.84 | $16.9K | ||
| Buy | 2026-01-06 | 20,000 | $0.79 | $15.8K | ||
| Buy | 2026-01-05 | 20,000 | $0.78 | $15.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Peer Group
Similar companies in the same sectorCompare PMCB with peers: PMCB vs BCLI · PMCB vs CYCN · PMCB vs IBO
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PMCB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
PharmaCyte Biotech, Inc. (PMCB) is currently trading at $0.35, trading near its 52-week low. It does not currently pay a regular dividend.
Does PMCB Pay a Dividend? PharmaCyte Biotech, Inc. Dividend Status
PharmaCyte Biotech, Inc. (PMCB) is a healthcare stock trading at $0.35. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest PMCB News
LiveProjected your PMCB DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.